eISSN: 1897-4252
ISSN: 1731-5530
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2006
vol. 3
 
Share:
Share:
abstract:

Anestezjologia i Intensywna Terapia
Pharmacological effects of nitric oxide in extracorporeal membrane oxygenation

Rame Taha
,
Gilbert Blaise

Kardiochirurgia i Torakochirurgia Polska 2006; 3 (4): 404–407
Online publish date: 2007/01/10
View full text Get citation
 
Nitric oxide (NO) is a gas that has potent vasodilator properties. It can be administered via inhalation in situations where NO production is impaired, and results in vasodilatation of the pulmonary capillaries. Extracorporeal membrane oxygenation (ECMO), a technique for providing life support to patients with cardiac and/or respiratory dysfunction, allows the heart and lungs to rest. Inhaled NO (INO) therapy reduces the need for ECMO in hypoxemic respiratory failure and persistent pulmonary hypertension (PPHN) in neonates; it is now the standard of care for this population. Our review will focus on the role of INO as an anti-inflammatory agent and vasodilator in various respiratory and cardiac diseases as well as its effect on the use of ECMO in term and premature infants.
keywords:

nitric oxide, extracorporeal membrane oxygenation, pulmonary hypertension

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.